US Stock MarketDetailed Quotes

ARCT Arcturus Therapeutics

Watchlist

18.340
+0.830+4.74%

Close Nov 29 13:00 ET

18.340
0.0000.00%

Post 17:01 ET

496.78MMarket Cap-7871P/E (TTM)

Arcturus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

26.67%-23.76M

-159.33%-30.14M

84.51%-5.56M

-156.57%-18.1M

-100.39%-629K

23.58%-32.41M

237.98%50.81M

26.85%-35.87M

123.69%31.99M

477.11%160.26M

Net income from continuing operations

57.45%-6.9M

67.24%-17.22M

-152.84%-26.82M

-417.95%-29.73M

-109.98%-11.71M

54.00%-16.22M

-143.70%-52.55M

199.19%50.75M

104.59%9.35M

403.51%117.35M

Operating gains losses

388.57%202K

--388K

100.16%53K

-3,904.83%-33.86M

--0

95.53%-70K

--0

-15,052.65%-33.79M

181.50%890K

568.86%3.35M

Depreciation and amortization

10.28%912K

23.34%909K

56.40%904K

93.65%2.96M

47.91%815K

98.32%827K

120.00%737K

158.04%578K

28.00%1.53M

77.74%551K

Other non cash items

----

-76.90%502K

--0

-8.06%502K

-68.91%2.17M

-497.74%-2.91M

Change In working capital

-4.80%-27.47M

-125.09%-23.65M

116.45%10.22M

158.78%7.38M

-95.91%1.45M

-34.90%-26.21M

522.93%94.24M

-895.57%-62.09M

-138.49%-12.56M

403.11%35.39M

-Change in receivables

82.74%-6.11M

-96.69%2.97M

105.58%5.01M

-4,959.04%-29.3M

955.00%6.16M

-17,548.77%-35.42M

6,110.80%89.68M

-27,591.05%-89.72M

148.55%603K

46.75%-720K

-Change in prepaid assets

79.55%-850K

-1,485.89%-2.26M

-51.95%2.19M

132.51%1.17M

135.28%609K

-349.30%-4.16M

106.79%163K

210.30%4.55M

-53.62%-3.58M

-5,467.74%-1.73M

-Change in payables and accrued expense

-257.98%-7.03M

149.71%5.05M

-51.43%6.2M

-144.64%-2.83M

-870.17%-9.89M

-24.72%4.45M

-301.83%-10.16M

455.13%12.77M

88.14%6.33M

86.65%-1.02M

-Change in other current assets

-8.24%935K

-12.35%880K

84.51%1.82M

23.93%4.05M

6.16%1.03M

6.04%1.02M

5.02%1M

164.88%988K

134.48%3.26M

--974K

-Change in other current liabilities

10.61%-977K

36.06%-688K

3.69%-991K

3.75%-4.31M

-10.88%-1.11M

68.55%-1.09M

-341.80%-1.08M

-131.24%-1.03M

-231.38%-4.48M

---1M

-Change in other working capital

-249.39%-13.43M

-302.41%-29.61M

-138.81%-4.01M

362.73%38.61M

-88.05%4.65M

140.68%8.99M

152.68%14.63M

378.79%10.34M

-144.81%-14.69M

1,540.68%38.88M

Cash from discontinued investing activities

Operating cash flow

26.67%-23.76M

-159.33%-30.14M

84.51%-5.56M

-156.57%-18.1M

-100.39%-629K

23.58%-32.41M

237.98%50.81M

26.85%-35.87M

123.69%31.99M

477.11%160.26M

Investing cash flow

Cash flow from continuing investing activities

91.85%-80K

7.34%-328K

65.27%-240K

62.45%-2.9M

77.02%-875K

55.12%-981K

-193.65%-354K

67.27%-691K

-126.83%-7.73M

-240.52%-3.81M

Net PPE purchase and sale

91.85%-80K

7.34%-328K

65.27%-240K

62.45%-2.9M

77.02%-875K

55.12%-981K

-193.65%-354K

67.27%-691K

-126.83%-7.73M

-240.52%-3.81M

Cash from discontinued investing activities

Investing cash flow

91.85%-80K

7.34%-328K

65.27%-240K

62.45%-2.9M

77.02%-875K

55.12%-981K

-193.65%-354K

67.27%-691K

-126.83%-7.73M

-240.52%-3.81M

Financing cash flow

Cash flow from continuing financing activities

-96.83%693K

2,456.38%2.4M

108.00%2.19M

-742.50%-24.09M

-735.89%-18.66M

1,890.16%21.84M

-63.42%94K

-8,244.05%-27.36M

-105.95%-2.86M

-1,070.43%-2.23M

Net issuance payments of debt

--0

-447.28%-27.36M

-566.67%-20M

1,100.00%20M

--0

---27.36M

-110.73%-5M

---3M

Net common stock issuance

----

48.18%609K

--0

----

-20.19%411K

--0

Proceeds from stock option exercised by employees

-99.11%11K

2,456.38%2.4M

--2.19M

54.22%2.67M

74.87%1.34M

233.60%1.23M

-63.42%94K

--0

91.80%1.73M

233.91%768K

Cash from discontinued financing activities

Financing cash flow

-96.83%693K

2,456.38%2.4M

108.00%2.19M

-742.50%-24.09M

-735.89%-18.66M

1,890.16%21.84M

-63.42%94K

-8,244.05%-27.36M

-105.95%-2.86M

-1,070.43%-2.23M

Net cash flow

Beginning cash position

-16.65%317.21M

4.61%345.28M

-11.44%348.89M

5.75%393.98M

53.93%369.05M

33.28%380.6M

2.58%330.05M

5.75%393.98M

-19.53%372.57M

-42.36%239.76M

Current changes in cash

-100.49%-23.15M

-155.53%-28.07M

94.35%-3.61M

-310.61%-45.09M

-113.07%-20.16M

74.79%-11.55M

239.69%50.55M

-25.80%-63.93M

123.67%21.41M

455.47%154.22M

End cash Position

-20.32%294.06M

-16.65%317.21M

4.61%345.28M

-11.44%348.89M

53.93%369.05M

33.28%380.6M

2.58%330.05M

5.75%393.98M

Free cash flow

28.58%-23.84M

-160.39%-30.47M

84.14%-5.8M

-186.54%-21M

-100.96%-1.5M

25.13%-33.39M

238.44%50.45M

28.52%-36.56M

117.53%24.27M

458.71%156.45M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	26.67%-23.76M	-159.33%-30.14M	84.51%-5.56M	-156.57%-18.1M	-100.39%-629K	23.58%-32.41M	237.98%50.81M	26.85%-35.87M	123.69%31.99M	477.11%160.26M
Net income from continuing operations	57.45%-6.9M	67.24%-17.22M	-152.84%-26.82M	-417.95%-29.73M	-109.98%-11.71M	54.00%-16.22M	-143.70%-52.55M	199.19%50.75M	104.59%9.35M	403.51%117.35M
Operating gains losses	388.57%202K	--388K	100.16%53K	-3,904.83%-33.86M	--0	95.53%-70K	--0	-15,052.65%-33.79M	181.50%890K	568.86%3.35M
Depreciation and amortization	10.28%912K	23.34%909K	56.40%904K	93.65%2.96M	47.91%815K	98.32%827K	120.00%737K	158.04%578K	28.00%1.53M	77.74%551K
Other non cash items	----	----	----	-76.90%502K	--0	--0	--0	-8.06%502K	-68.91%2.17M	-497.74%-2.91M
Change In working capital	-4.80%-27.47M	-125.09%-23.65M	116.45%10.22M	158.78%7.38M	-95.91%1.45M	-34.90%-26.21M	522.93%94.24M	-895.57%-62.09M	-138.49%-12.56M	403.11%35.39M
-Change in receivables	82.74%-6.11M	-96.69%2.97M	105.58%5.01M	-4,959.04%-29.3M	955.00%6.16M	-17,548.77%-35.42M	6,110.80%89.68M	-27,591.05%-89.72M	148.55%603K	46.75%-720K
-Change in prepaid assets	79.55%-850K	-1,485.89%-2.26M	-51.95%2.19M	132.51%1.17M	135.28%609K	-349.30%-4.16M	106.79%163K	210.30%4.55M	-53.62%-3.58M	-5,467.74%-1.73M
-Change in payables and accrued expense	-257.98%-7.03M	149.71%5.05M	-51.43%6.2M	-144.64%-2.83M	-870.17%-9.89M	-24.72%4.45M	-301.83%-10.16M	455.13%12.77M	88.14%6.33M	86.65%-1.02M
-Change in other current assets	-8.24%935K	-12.35%880K	84.51%1.82M	23.93%4.05M	6.16%1.03M	6.04%1.02M	5.02%1M	164.88%988K	134.48%3.26M	--974K
-Change in other current liabilities	10.61%-977K	36.06%-688K	3.69%-991K	3.75%-4.31M	-10.88%-1.11M	68.55%-1.09M	-341.80%-1.08M	-131.24%-1.03M	-231.38%-4.48M	---1M
-Change in other working capital	-249.39%-13.43M	-302.41%-29.61M	-138.81%-4.01M	362.73%38.61M	-88.05%4.65M	140.68%8.99M	152.68%14.63M	378.79%10.34M	-144.81%-14.69M	1,540.68%38.88M
Cash from discontinued investing activities
Operating cash flow	26.67%-23.76M	-159.33%-30.14M	84.51%-5.56M	-156.57%-18.1M	-100.39%-629K	23.58%-32.41M	237.98%50.81M	26.85%-35.87M	123.69%31.99M	477.11%160.26M
Investing cash flow
Cash flow from continuing investing activities	91.85%-80K	7.34%-328K	65.27%-240K	62.45%-2.9M	77.02%-875K	55.12%-981K	-193.65%-354K	67.27%-691K	-126.83%-7.73M	-240.52%-3.81M
Net PPE purchase and sale	91.85%-80K	7.34%-328K	65.27%-240K	62.45%-2.9M	77.02%-875K	55.12%-981K	-193.65%-354K	67.27%-691K	-126.83%-7.73M	-240.52%-3.81M
Cash from discontinued investing activities
Investing cash flow	91.85%-80K	7.34%-328K	65.27%-240K	62.45%-2.9M	77.02%-875K	55.12%-981K	-193.65%-354K	67.27%-691K	-126.83%-7.73M	-240.52%-3.81M
Financing cash flow
Cash flow from continuing financing activities	-96.83%693K	2,456.38%2.4M	108.00%2.19M	-742.50%-24.09M	-735.89%-18.66M	1,890.16%21.84M	-63.42%94K	-8,244.05%-27.36M	-105.95%-2.86M	-1,070.43%-2.23M
Net issuance payments of debt	--0	--0	--0	-447.28%-27.36M	-566.67%-20M	1,100.00%20M	--0	---27.36M	-110.73%-5M	---3M
Net common stock issuance	----	----	----	48.18%609K	--0	----	----	----	-20.19%411K	--0
Proceeds from stock option exercised by employees	-99.11%11K	2,456.38%2.4M	--2.19M	54.22%2.67M	74.87%1.34M	233.60%1.23M	-63.42%94K	--0	91.80%1.73M	233.91%768K
Cash from discontinued financing activities
Financing cash flow	-96.83%693K	2,456.38%2.4M	108.00%2.19M	-742.50%-24.09M	-735.89%-18.66M	1,890.16%21.84M	-63.42%94K	-8,244.05%-27.36M	-105.95%-2.86M	-1,070.43%-2.23M
Net cash flow
Beginning cash position	-16.65%317.21M	4.61%345.28M	-11.44%348.89M	5.75%393.98M	53.93%369.05M	33.28%380.6M	2.58%330.05M	5.75%393.98M	-19.53%372.57M	-42.36%239.76M
Current changes in cash	-100.49%-23.15M	-155.53%-28.07M	94.35%-3.61M	-310.61%-45.09M	-113.07%-20.16M	74.79%-11.55M	239.69%50.55M	-25.80%-63.93M	123.67%21.41M	455.47%154.22M
End cash Position	-20.32%294.06M	-16.65%317.21M	4.61%345.28M	-11.44%348.89M	-11.44%348.89M	53.93%369.05M	33.28%380.6M	2.58%330.05M	5.75%393.98M	5.75%393.98M
Free cash flow	28.58%-23.84M	-160.39%-30.47M	84.14%-5.8M	-186.54%-21M	-100.96%-1.5M	25.13%-33.39M	238.44%50.45M	28.52%-36.56M	117.53%24.27M	458.71%156.45M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data